SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Bispecific Monoclonal Antibody 

Prev Next
Previous

Thrombopoeitin Receptor Agonist

medical illustration of A bispecific monoclonal antibody is engineered to simultaneously bind to a cytotoxic cell and a targeted tumor cell.
Next medical illustration of APC Dendritic Cells play a critical role initiating tumor destruction by activating T Cells. Tumor cells produce antigens that are captured by antigen presenting cells (APCs). The APCs that activate T-Cells are usually dendritic cells because T Cells cannot recognize or respond to free or soluble antigens but they can recognize and respond to antigens that have been processed and presented by APC dendritic cells.

APC Dendritic Cell Initiates T Cell Activation for

A bispecific monoclonal antibody is engineered to simultaneously bind to a cytotoxic cell and a targeted tumor cell.

Keywords: Airbrush, 3D, Advertising / Marketing, Allergy / Immunology, Biotechnology, Cell biology / Histology, Disease Management, Molecular Biology, Pharmacology, Mechanism of Action (MOA)

© Edmond Alexander